Release date: 2016-02-17 Founded in 2014, D-EYE has offices in Italy and California. The company is mainly engaged in the development of mobile sensors, testing equipment and its associated applications, and to conduct health checks and data collection. In addition, the company also develops a cloud-based service platform, one of which can meet the needs of telemedicine, and the other can integrate and analyze health check data to understand the patient's condition and provide quality services to patients. D-EYE provides people with a "digital eye" that can detect the state of the body. The company recently completed $1.68 million in financing, including Innogest, Invitalia Ventures, Giuseppe e Annamaria Cottino Foundation and Si14. The funds are mainly used to develop D-Eye , a smartphone - based retinal imaging system. D-Eye was conceived by Andrea Russo, an ophthalmologist in Padua, Italy. "At the time he was checking the patient, the phone rang, and he had the idea of ​​developing a mobile retinal imaging system," said Rick Sill, CEO of D-Eye. “He looked at his smartphone and said, 'Since you can capture images with your smartphone now, can you use it as a digital ophthalmoscope? If you can, I can use the phone to capture the acquired eye image. Sent to other doctors.' Sill said in a talk show "He went out and bought a 3D printer and started to realize his idea - print a lens and mount it on a smartphone as a retina imaging equipment." Russo and Si14 have established a partnership to develop the product together. In May 2015, D-Eye was released. The company now has offices in Italy and California, and has launched an external device that can be connected to an iPhone or Samsung smartphone. Once connected, it can be eye-checked. The external device is synchronized with the companion app and uses the smartphone's LED lights to capture high-resolution pictures and videos of the retina. Equipment costs $435. D-Eye can help doctors diagnose various eye diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration, visual impairment, neuritis, and hypertensive retinopathy. In addition, the product can also be used in animals such as dogs, cats, rabbits, horses, falcons, and the like. Sill said the company will use new funds to promote the use of D-Eye. Although D-Eye has now attracted the attention of medical professionals such as ophthalmologists, optometrists, pediatricians, neurologists, etc., D-Eye's ultimate goal is to allow general practitioners, nurses, emergency medical technicians, especially those D-Eye is used by people working in the emergency room of the hospital. "Our company's mission is to use smartphones to help the world's 300 million people with vision loss - they live in remote rural areas without medical care," Sill said. The company is currently beta testing a D-Eye image library for cloud storage services powered by TreVia Digital Health. The captured images and videos will be sent to the D-Eye Image Library for further analysis if necessary. Source: Arterial Network Xylo-Oligosaccharide Food Additive,Sweetener Powder Xylo-Oligosaccharide,Xylo-Oligosaccharides Top Quality Shandong Bailong Chuangyuan Bio-tech Co.,Ltd. Qingdao Branch , https://www.sdblcycn.com